The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat ...

Manipal Hospitals Sarjapur Road recently hosted an awareness session on Holmium Laser Enucleation of the Prostate (HoLEP), an ...

for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adult males on pharmacological therapy for benign prostatic hyperplasia ...

The treatment of benign prostatic hyperplasia (BPH) that causes lower urinary tract symptoms has advanced enormously since the days when it was a simple choice between no treatment with ...

The procedure's precision reduces the risk of complications, making it an optimal choice for individuals seeking treatment for BPH. “The remarkable technology empowers urologists to leverage our ...

[69] conducted a multicenter, randomized study of 1051 patients with BPH. Patients received ER alfuzosin ... peak urinary flow rates were similar among the three treatment groups.

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...